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Background: Hairy and Enhancer of split 1 (Hes-1) is a transcriptional repressor that plays an important role in neuronal
differentiation and development, but post-translational modifications of Hes-1 are much less known. In the present study,
we aimed to investigate whether Hes-1 could be SUMO-modified and identify the candidate SUMO acceptors on Hes-1.
We also wished to examine the role of the SUMO E3 ligase protein inhibitor of activated STAT1 (PIAS1) in SUMOylation
of Hes-1 and the molecular mechanism of Hes-1 SUMOylation. Further, we aimed to identify the molecular target of
Hes-1 and examine how Hes-1 SUMOylation affects its molecular target to affect cell survival.
Results: In this study, by using HEK293T cells, we have found that Hes-1 could be SUMO-modified and Hes-1
SUMOylation was greatly enhanced by the SUMO E3 ligase PIAS1 at Lys8, Lys27 and Lys39. Furthermore, Hes-1
SUMOylation stabilized the Hes-1 protein and increased the transcriptional suppressing activity of Hes-1 on
growth arrest and DNA damage-inducible protein alpha (GADD45α) expression. Overexpression of GADD45α increased,
whereas knockdown of GADD45αα expression decreased cell apoptosis. In addition, H2O2 treatment increased the
association between PIAS1 and Hes-1 and enhanced the SUMOylation of Hes-1 for endogenous protection.
Overexpression of Hes-1 decreased H2O2-induced cell death, but this effect was blocked by transfection of the
Hes-1 triple sumo-mutant (Hes-1 3KR). Overexpression of PIAS1 further facilitated the anti-apoptotic effect of
Hes-1. Moreover, Hes-1 SUMOylation was independent of Hes-1 phosphorylation and vice versa.
Conclusions: The present results revealed, for the first time, that Hes-1 could be SUMO-modified by PIAS1 and
GADD45α is a novel target of Hes-1. Further, Hes-1 SUMOylation mediates cell survival through enhanced suppression
of GADD45α expression. These results revealed a novel role of Hes-1 in addition to its involvement in Notch signaling.
They also implicate that SUMOylation could be an important posttranslational modification that regulates cell survival.
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Hairy and Enhancer of split 1 (Hes-1) is a transcriptional
repressor belongs to the basic helix-loop-helix (bHLH)
protein family, and was shown to play a pivotal role in
regulation of cell differentiation and proliferation in various
cell types during development [1]. Hes-1 is a Notch ef-
fector and can repress the transcription of its target genes* Correspondence: eminy@gate.sinica.edu.tw
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unless otherwise stated.through sequestration of other transcription activators or
recruitment of cofactors [2]. Through forming homodi-
mers, Hes-1 directly binds to the N-box (CACNAG) of tar-
get gene promoter and recruits transducin-like enhancer
to repress transcription. Hes-1 also forms heterodimers
with other bHLH activators and sequesters them from
binding to the E-box (CANNTG) of target gene promoter
and that results in passive repression.
The repression activity of Hes-1 can be regulated by
protein phosphorylation. Our recent finding indicates thattd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
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http://www.jbiomedsci.com/content/21/1/53phosphorylation of Hes-1 at Ser263 by c-Jun N-terminal
kinase 1 (JNK1) stabilizes the Hes-1 protein and enhances
its suppressing effect on α-amino-3-hydroxy-5-methyl-4-
isoxazolepropionic acid receptor subunit GluR1 expres-
sion [3]. Moreover, phosphorylation at protein kinase C
consensus sites (Ser37, Ser38) in the basic domain of
Hes-1 inhibits the DNA-binding activity of Hes-1
during nerve growth factor stimulation of PC12 cell
differentiation [4]. In addition, Hes-1 phosphorylation
by calmodulin-dependent protein kinase II delta turns
it from a repressor to an activator that is required for
neuronal stem cell differentiation [5]. But in addition
to Hes-1 phosphorylation, whether other posttransla-
tional modification also occurs to Hes-1 is barely
known.
Post-translational modification of proteins with small
ubiquitin-like modifier (SUMO) has been recognized as
an important mechanism for regulation of various cellu-
lar functions [6]. SUMO is a polypeptide about 100
amino acids in length that is covalently attached to sub-
strate proteins on the lysine (Lys) residue. In the SUMO
pathway, SUMO precursors are first processed by SUMO-
specific proteases and activated by E1 enzyme, and subse-
quently transferred to the E2 conjugation enzyme UBC9.
The SUMO E3 ligases then transfer the SUMO molecule
from UBC9 to specific substrate proteins [7]. Protein in-
hibitor of activated STAT1 (PIAS1) is a SUMO E3 lig-
ase belongs to the PIAS protein family that is well
studied in the immune system [8,9]. Through ligase
activity-dependent or -independent mechanism, PIAS1
regulates the activity of distinct proteins, including
transcription factors [10]. For example, we have previ-
ously shown that PIAS1 facilitates spatial learning and
memory in rats through enhanced SUMOylation of
STAT1 and decreased phosphorylation of STAT1 [11]. Fur-
ther, PIAS1 promotes the SUMOylation of mastermind-
like 1 (MAML1), a co-activator of NICD, and enhances its
association with histone deacetylase 7 and decreases the
transcriptional activity of MAML1 [12]. The latter re-
sults indicate that PIAS1 could modulate Notch signal-
ing through SUMOylation of different transcriptional
co-repressors or co-activators of the Notch signaling
pathway. In the present study, we examined whether
PIAS1 could modulate the activity of the Notch ef-
fector Hes-1 through SUMOylation of Hes-1. We also




Cycloheximide and N-ethylmaleimide (NEM) were pur-
chased from Sigma-Aldrich (St. Louis, MO, USA). Calf
intestinal phosphatase (CIP) was purchased from NEB
(Ipswich, MA, USA).In vitro SUMOylation assay
In vitro sumoylation assay was performed using the
SUMO link™ kit according to the manufacturer’s ins-
tructions (Active Motif, Carlsbad, CA). Briefly, purified
recombinant proteins were mixed and incubated at 30°C
for 4 h, and the reaction was stopped by boiling in
Laemmli sample buffer at 95°C for 10 min. The product
was analyzed by 10% SDS-PAGE then transferred onto
the PVDF membrane (Millipore, Bedford, MA). The mem-
brane was immunoblotted with antibodies against Hes-1
(GeneTex, Irvine, CA) and SUMO-1 (Active Motif).
Plasmid DNA construction
For construction of the Flag-tagged pias1 plasmid, full-
length pias1 was cloned by amplifying the rat pias1
cDNA. The PCR product was subcloned between the
BamHI and EcoRI sites of the expression vector pCMV-
Tag2A. Flag-tagged pias2, pias3 and pias4 plasmids were
prepared in the same way. The PCR products were sub-
cloned between the EcoRI and XhoI sites of the expression
vector pCMV-Tag2A. For construction of the EGFP-
tagged pias1 plasmid, full-length pias1 was subcloned into
the pEGFP-C1 expression vector with RsrII site. For con-
struction of the Flag-tagged Hes-1 plasmid, full-length
Hes-1 was cloned by amplifying the rat Hes-1 cDNA. The
PCR product was subcloned between the BamHI and
EcoRI sites of the expression vector pCMV-Tag2B. For
construction of the Flag-tagged Hes-5 plasmid, full-length
Hes-5 was cloned by amplifying the rat Hes-5 cDNA. The
PCR product was subcloned between the BamHI and
EcoRI sites of the expression vector pCMV-Tag2B. For
construction of the Flag-tagged RanBP2(ΔFG) plasmid,
partial-length RanBP2 (amino acid 2553-2838) was cloned
by amplifying the human kidney RanBP2 cDNA. The PCR
product was subcloned between the EcoRI and XhoI sites
of the expression vector pCMV-Tag2B. For construction
of the Flag-tagged Pc2 plasmid, full-length Pc2 was cloned
by amplifying the rat Pc2 cDNA. The PCR product was
subcloned between the EcoRI and XhoI sites of the expres-
sion vector pCMV-Tag2A. For construction of the Myc-
tagged sumo-1 plasmid, full-length sumo-1 was cloned by
amplifying the mouse sumo-1 cDNA. The PCR product
was subcloned between the XmaI and KpnI sites of the ex-
pression vector pCMV-Myc. For construction of the His-
tagged ubiquitin plasmid, full-length ubiquitin was cloned
by amplifying the human ubiquitin cDNA. The PCR prod-
uct was subcloned between the NcoI and BamHI sites
of the expression vector CMV-3 × His tag vector. The
pias1S90A and pias1W372A mutant plasmids, Hes-1
phosphorylation mutants and sumo-mutant plasmids
were generated by using the QuickChange Site-Directed
Mutagenesis Kit (Stratagene, La Jolla, CA). For construc-
tion of the human GADD45α promoter-luciferase fusion
plasmid (pGL3-GADD45α -P), nt.-920 ~ nt. + 289 of
Table 2 siRNA sequences
Pias1 #1 sense: 5’-AGAAAUGUACAGAGAACAAdTdT -3’
antisense: 5’-UUGUUCUCU GUACAUUUCUdTdT -3’






Hes-1 #1 sense: 5’-CCACGUGCGAGGGCGUUAAdTdT-3’
antisense: 5’-UUAACGCCCUCGCACGUGGdTdT-3’
Hes-1 #2 Target 1: 5’-CGAAGAGCAAGAAUAAAUG-3’
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tor (Promega, Madison, WI) between SacI and BglII restric-
tion enzyme sites. The nt.-920 ~ nt. + 289 of GADD45α
promoter region was generated by PCR amplification from
human genomic DNA. The primer sequences used for the
above plasmid cDNAs are summarized in Table 1.
RNA interference
Various siRNAs were used to knock down the expres-
sion of individual proteins specifically. For PIAS1 and
Hes-1, two sets of different siRNAs were used. The
sense and antisense sequences for all the siRNA used are
summarized in Table 2. The Silencer Negative Control
number 1 siRNA (control siRNA) was used as a control.
These are the siRNAs with sequences that do not target
any gene product (Ambion, Austin, TX).
Cell culture and plasmid transfection
HEK293T cells were grown in DMEM (Hyclone, Logan,
UT, USA) supplemented with 10% fetal bovine serum
(Hyclone) in a humidified atmosphere at 5% CO2 at
37°C. Cells were transfected with various plasmids by
Lipofectamin 2000 24 h after seeding (Invitrogen, Carlsbad,
























TC-3’Lipofectamine 2000 was pre-mixed with 100 μl of DMEM
at a ratio of DNA: Lipofectamine = 1 μg: 2.5 μl for 5 min at
room temperature. Plasmid DNA was resolved in 100 μl
DMEM and mixed with the pre-mixed Lipofectamine.
After incubation for 20 min at room temperature, the
mixture was added to cells in culture medium without
antibiotics.
Immunoprecipitation (IP) assay
Cells transfected with plasmid DNA were lysed in RIPA
buffer with the addition of protease inhibitor and phos-
phatase inhibitor (Roche). The cell extracts were harvested
by centrifugation at 4°C for 10 min and the supernatant
was used for IP assay. Cell extracts (500 μg) were incu-
bated with 20 μl of anti-Flag M2 affinity gel (50% slurry)
(Sigma-Aldrich, St. Louis, MO) at 4°C for 2 h. Immuno-
precipitates were collected by centrifugation at 1000 × g,
washed with RIPA buffer for three times followed by SDS-
PAGE electrophoresis and western blot. For co-IP assay,
cells were co-transfected with equal amount of Tag-
fusioned constructs and lysed 48 h later. Anti-Flag M2
affinity gel (50% slurry) (Sigma-Aldrich) and EGFP anti-
body (Roche) were used for IP of protein complex from
cell extract at 4°C for 2 h. After washing with PBS for
three times, the immunoprecipitates were eluted by sam-
pling buffer and subject to SDS-PAGE and western blot.
Western blot
HEK293T cells were lysed in RIPA buffer [50 mM Tris-
HCl (pH 7.4), 150 mM NaCl, 2 mM EDTA, 1% IGEPAL
CA-630, 1 mM phenymethylsulfonyl fluoride (PMSF),
20 mg/ml pepstatin A, 20 mg/ml leupeptin, 20 mg/ml
aprotinin, 50 mM NaF and 1 mM Na3VO4] and the
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14,000 rpm to remove the debris. The lysate was re-
solved by 10% or 12% SDS-PAGE and proteins sepa-
rated by SDS-PAGE were transferred onto the PVDF
membrane for antibody conjugation. The antibodies
used include: anti-Flag M2 (Sigma-Aldrich, St. Louis,
MO), anti-actin (Millipore), anti-EGFP (Roche, Penzberg,
Germany), anti-GADD45α (Santa Cruz Biotechnology,
Santa Cruz, CA), anti-SUMO-1 (Active Motif ), anti-
SUMO-2 (Epitomics, Burlingame, CA), anti-Hes-1 (Gene-
Tex), anti-pSer263 Hes-1 [3], anti-PIAS1 (Epitomics),
anti-pSer90PIAS1 (LTK BioLaboratories, Taoyuan, Taiwan),
anti-α-His (Millipore) and anti-Myc (Millipore) antibodies.
The secondary antibodies used were HRP-conjugated
goat-anti-mouse IgG antibody and HRP-conjugated goat-
anti-rabbit IgG antibody (Jackson ImmunoResearch
Laboratories, West Grove, PA). Membrane was devel-
oped by reacting with chemiluminescence HRP substrate
(Millipore) and exposed to the LAS-3000 image system
(Fujifilm, Tokyo, Japan) for visualization of protein bands.Promoter activity assay
Cells were plated at a density of 5 × 104 cells/well and
transfected with 0.4 μg of pGL3-GADD45α-P promoter-
firefly luciferase reporter plasmid, 0.001 μg pRL (Rellina)
and 1.2 μg of various plasmid DNA 24 h later. The total
mass of transfected DNA in each well was kept constant
by adding empty vector plasmid DNA when necessary.
Forty-eight hours after transfection, cells were washed
with PBS and lysed with 1× Passive Lysis Buffer (Promega).
Luciferase activity was determined using the Dual-Glo
luciferase assay system (Promega) and the TD-20/20
Luminometer (Turner Designs Hydrocarbon Instru-
ments). The relative activity was normalized to the
Rellina activity.Quantitative real-time PCR
Total RNA was isolated using the RNAspin mini kit (GE
Healthcare, Buckinghamshire, Germany). Purified RNA
(1 μg) was reverse-transcripted to cDNA by SuperScript
III reverse transcriptase (Invitrogen). Quantitative real-
time PCR was performed using the ABI PRISM 7500
real-time PCR system with Power SYBR Green PCR re-
agents (Fermentas, Vilnius, Lithuania) according to the
instruction manual (Applied Biosystem, ABI, Foster City,
CA). The primer sequences for GADD45α are as follows:
5′-GAGAGCAGAAGACCGAAAGGA-3′ (forward) and
5′-CACAACACCACGTTATCGGG-3′ (reverse). HPRT
was used as an internal control for each sample. The
primer sequences for HPRT are: 5′-TGTGTGCTCAA
GGGGGGC-3′ (forward) and 5′-CGTGGGGTCCTTT
TCACC-3′ (reverse). The amount of gadd45α gene ex-
pression is normalized to that of HPRT gene expression.Chromatin immunoprecipitation (ChIP) assay
ChIP was performed according to the manufacturer’s
protocol (Millipore). Briefly, nuclear chromatin extracts
were incubated with antibody against Hes-1 (Novus,
Littleton, CO) (4.8 μg of anti-Hes-1 or mouse IgG) or
Flag-M2 (Sigma-Aldrich) at 4°C overnight. Immuno-
precipitates were collected on magnesium beads for
another 1-2 h at 4°C. After thorough washing, immu-
noprecipitates were de-crosslinked and chromatin was
recovered for quantitative PCR analysis. Primers used
for GADD45α promoter are: 5′-TCATGATTCAGCAT
CTAACATCAATAA-3′ (forward) and 5′-GACAACCA
TCTGACACCC-3′ (reverse).
Immunofluorescence staining
Immunofluorescence staining was performed as de-
scribed previously [3]. HEK293T cells were fixed with
4% paraformaldehyde/4% sucrose for 10 min followed
by permeabilization with 0.1% Triton X-100 for 20 min
at room temperature. Primary antibody against Hes-1
(GeneTex) (1:100) was added to the cells with 0.5% bovine
serum albumin at 4°C overnight. Cy5 donkey anti-rabbit
antibody (Jackson ImmunoResearch Laboratories) (1:500)
was incubated with cells for 1 h at room temperature. After
washed with PBS, cells were stained with DAPI and exam-
ined under a fluorescence microscope.
Cytotoxicity assay
The cytotoxicity of H2O2 on HEK293T cells was deter-
mined by using CCK-8 assay (Cell Counting Kit, Boster
Biological Technology, Ltd., Fremont, CA) [13]. Cells
were seeded in 96-well plate at a density of 4 × 103 cells/
well in 100 μl of culture medium. After incubation for
24 h, the cells were transfected with various plasmids by
Lipofectamine 2000. Forty-eight hours after transfection,
cells were treated with different concentrations of H2O2
for 4 h. Next, 10 μl (1/10 v/v) of CCK-8 reagent was
added to each well and incubated for another 2 h in in-
cubator. Wells containing no cell (medium only) but
treated with CCK-8 were used as the blank control, and
cells transfected with vector plasmid and CCK-8 but no
H2O2 challenge served as the negative control. After incu-
bation, cell viability was determined by using the micro-
plate reader (SpectraMax340pc384, Molecular Devices,
Sunnyvale, CA) with absorbance set at 450 nm. The
absorbance reading from each well was used to calculate
the cell survival rate. Survival rate(%) = [optical density
(OD)of the treated cells −OD of blank control/OD of nega-
tive control −OD of blank control] × 100(%).
Terminal deoxynucleotidyl transferase dUTP nick end
labeling (TUNEL) assay
HEK293T cells were plated in 24-well plates at a density
of 2 × 104 cells/well. Twenty-four hours after plating,
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eight hours after transfection, cells were treated with differ-
ent concentrations of H2O2 and subject to TUNEL assay.
TUNEL assay was performed using Apoptag plus peroxid-
ase in situ apoptosis detection kit (Millipore). Briefly, after
H2O2 treatment, cells were fixed in 1% paraformaldehyde
for 10 min at room temperature and post-fixed by EtOH/
CH3COOH (2:1) for 5 min at -20°C. Cells were then incu-
bated with TdT enzyme for 1 h at 37°C followed by incuba-
tion with anti-digoxigenin peroxidase for 30 min at room
temperature. The apoptotic cells yield brown color after
DAB staining viewed from a light microscope.
Statistics
Data are analyzed by Student’s t-test (for two groups) or
one-way analysis of variance followed by Newman-Keul
multiple comparisons (for more than two groups). Sta-
tistically significant levels are tested at p < 0.05, p < 0.01
and p < 0.001.
Results
Hes-1 is a SUMO substrate of PIAS1
To examine whether Hes-1 could be SUMO-modified,
recombinant Hes-1 protein was subject to in vitro
SUMOylation assay and western blot. Results showed
that a band around 55 kDa was observed when E1, E2,
SUMO-1 and Hes-1 proteins were added to the reac-
tion (Figure 1A, left panel). The ratio of sumoylated
Hes-1 versus un-sumoylated Hes-1 is approximately
8%. This band was also recognized by the SUMO-1
antibody (Figure 1A, right panel), indicating that Hes-
1 can be sumoylated in vitro. Next, Flag-Hes-1 plasmid
was transfected to HEK293T cells with or without the
addition of NEM, a potent SUMO protease inhibitor
[14]. Immunoblotting using anti-Flag antibody resolved
a major band around 40 kDa in all lysates, but three
slowly migrating bands near 55 kDa were also ob-
served in cell lysates treated with NEM (Figure 1B), in-
dicating that these bands may be the sumoylated form
of Hes-1. The reason for observation of three migrat-
ing bands is probably because poly-sumoylation occurs
to Hes-1 that makes the molecular weight of sumoy-
lated Hes-1 different. In addition, the slowly migrating
band just above the 43 kDa of Hes-1 is probably the
phosphorylated Hes-1 because we have later found that
treatment of the phosphatase CIP prevented the observa-
tion of this band. To confirm that both SUMO-1 and
SUMO-2 can be conjugated to Hes-1, Flag-Hes-1 plasmid
was transfected to HEK293T cells and cells were immuno-
precipitated with anti-Flag antibody followed by immuno-
blotting with different antibodies. Results revealed that
the slowly migrating bands were also observed when
immunoblotted with the anti-Hes-1, anti-SUMO-1 or
anti-SUMO-2 antibody (Figure 1C). Next, we examinedwhether endogenous Hes-1 could be sumo-modified.
HEK293T cell lysates were directly immunoprecipitated
with anti-Hes-1 antibody (or IgG) and immunoblotted
with anti-Hes-1 and anti-SUMO-1 antibodies. Results
showed that under this condition, the SUMO-Hes-1
bands were interfered by the heavy chain (Figure 1D,
left panel). We therefore transfected the Myc-SUMO-1
plasmid to HEK293T cells (without co-transfection of
Hes-1 plasmid) and the cell lysates were immunopreci-
pitated with anti-Myc antibody and immunoblotted
with anti-Hes-1 and anti-SUMO-1 antibodies. Results
revealed that endogenous Hes-1 SUMOylation could be
observed under this situation (Figure 1D, right panel). We
then examined whether PIAS1 is associated with Hes-1
endogenously. The HEK293T cell lysates were directly
immunoprecipitated with anti-PIAS1 antibody without
any plasmid transfection and immunoblotted with anti-
Hes-1 and anti-PIAS1 antibody. Result revealed that
PIAS1 is associated with Hes-1 endogenously (Figure 1E).
However, because we aimed to examine the effects of
Hes-1WT and Hes-1 sumo-mutants on cell survival in the
present study, but the Hes-1 sumo-mutant proteins are
not present in the cells endogenously, we have therefore
adopted the overexpression strategy for the subsequent
experiments. We also examined the possible SUMOyla-
tion of Hes-5, another member of the Hes protein fam-
ily. Results revealed a dose-dependent increase in Hes-
1 SUMOylation upon Hes-1 plasmid transfection to
HEK293T cells (Figure 1F), but none of these doses of
Hes-5 plasmid transfection resulted in Hes-5 SUMOy-
lation (Figure 1G).
PIAS1 is associated with Hes-1 and enhances the
SUMOylation of Hes-1
The above results indicated that in vivo Hes-1 SUMOy-
lation is more apparent than that observed in vitro, it
suggests that other components in the SUMO machin-
ery contribute to Hes-1 SUMOylation in the cell, par-
ticularly the E3 ligase, which is known to promote the
SUMOylation reaction and enhance substrate specificity
[7]. There are three families of the SUMO E3 ligase in-
cluding PIAS [15], RanBP2 [16] and Pc2 [17]. Further-
more, the PIAS family consists of different members of
the PIAS protein, including PIAS1, PIAS2, PIAS3 and
PIAS4 [18]. Here, we examined whether these E3 ligases
enhance the SUMOylation of Hes-1. EGFP-Hes-1 and
Myc-SUMO-1 were co-transfected with Flag-RanBP2 (ΔFG),
Flag-Pc2 or individual Flag-PIAS plasmid (PIAS1 to PIAS4)
to HEK293T cells and subject to western blot. Results re-
vealed that Hes-1 SUMOylation could be enhanced by
PIAS1, PIAS2 and PIAS3, but not by PIAS4 and RanBP2
(ΔFG) (Figure 2A). Overexpression of Pc2 at different
doses did not promote the SUMOylation of Hes-1 ei-




Figure 1 Hes-1 is sumoylated both in vitro and in vivo. (A) Recombinant Hes-1 protein was purified from E. coli. and in vitro SUMOylation
assay was carried out in the presence (or absence) of E1, E2, and SUMO-1 followed by western blot against Hes-1 (left panel) or SUMO-1 (right
panel). (B) Flag-Hes-1 WT plasmid was transfected to HEK293T cells and the cell lysate was subject to western blot against Flag. (C) HEK293T cells
were transfected with Flag-vector or Flag-Hes-1WT plasmid and the cell lysate was subject to immunoprecipitation with anti-Flag antibody and
immunoblotting with antibody against Hes-1 (left), SUMO-1 (middle) or SUMO-2 (right). (D) HEK293T cells were lysed and immunoprecipitated
with anti-Hes-1 (or IgG) antibody and immunoblotted with anti-Hes-1 (left) or anti-SUMO-1 (right) antibody (left panel). Myc-SUMO-1 plasmid
was transfected to HEK293T cells and the cell lysate was immunoprecipitated with anti-Myc antibody and immunoblotted with anti-Hes-1 or
anti-SUMO-1 antibody (right panel). (E) HEK293T cell lysate was immunoprecipitated with anti-PIAS1 antibody and immunoblotted with
anti-Hes-1 or anti-PIAS1 antibody. (F) EGFP-PIAS1 plasmid, Myc-SUMO-1 plasmid and different doses of Flag-Hes-1 plasmid were transfected
to HEK293T cells and the cell lysates were subject to western blot using antibodies against Flag, EGFP and Myc. (G) EGFP-PIAS1 plasmid,
Myc-SUMO-1 plasmid and different doses of Flag-Hes-5 plasmid were transfected to HEK293T cells and the cell lysates were subject to western
blot using antibodies against Flag, EGFP and Myc. The sumoylated Hes-1 bands are shown in the bracket. Each experiment was performed twice.
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transfected siRNA against PIAS1, PIAS2 and PIAS3 to
HEK293T cells, respectively and have found that, con-
sistent with the result of overexpression, PIAS1 siRNA
and PIAS3 siRNA more apparently decreased the SUMOy-
lation of Hes-1 (Figure 2C).
Both PIAS proteins and Hes-1 are suggested to lo-
cate in the nucleus [19,20]. Next, we examined the
sub-cellular localization of PIAS1 and Hes-1 in HEK293Tcells by immunofluorescence staining. DAPI was used as
a nuclear marker. Results revealed that both PIAS1
and Hes-1 showed nuclear localization and the merged
image indicated that PIAS1 is co-localized with Hes-1
(Figure 2D). Co-immunoprecipitation assay also showed a
physical association between PIAS1 and Hes-1 in the cell
(Figure 2E). We then determined whether Hes-1 SUMOyla-
tion by PIAS1 depends on the ligase activity of PIAS1.
PIAS1W372A was used for this purpose because Trp372 of
AB C
D E
Figure 2 H2O2 enhances the SUMOylation of Hes-1. (A) Flag-Hes-1WT plasmid was transfected to HEK293T cells with the addition of different
concentrations of H2O2 and the cell lysate was immunoprecipitated with anti-Flag antibody and immunoblotted with anti-Hes-1 (left) or anti-SUMO-1
(right) antibody. (B) Flag-Hes-1WT plasmid was transfected to HEK293T cells with the addition of 0.2 mM H2O2 for different time periods. The cell lysate
was immunoprecipitated with anti-Flag antibody and immunoblotted with anti-Hes-1 (left) or anti-SUMO-1 (right) antibody. (C) Myc-SUMO-1 plasmid
was transfected to HEK293T cells with the addition of 0.2 mM H2O2 for 4 h. The cell lysate was immunoprecipitated with anti-Myc antibody and
immunoblotted with anti-Hes-1 and anti-SUMO-1 antibody. (D) H2O2 (0.2 mM) was added to HEK293T cells for different time periods and
the cell lysate was subject to western blot against pSer-90 PIAS1 and PIAS1 (upper panel). Flag-Hes-1WT plasmid was transfected to HEK293T
cells with co-transfection of EGFP-PIAS1WT or EGFP-PIAS1S90A plasmid and with the addition of H2O2 for 4 h and the cell lysate was immunoprecipitated
with anti-Flag antibody and immunoblotted with antibodies against PIAS1 and Flag. Western blot against EGFP and Flag for cell lysates only was used as a
control for transfection and expression (lower panel). (E) Flag-Hes-1WT plasmid was co-transfected with EGFP-PIAS1 and Myc-SUMO-1 plasmids, and H2O2
was added to some of these groups for 4 h. The phosphatase inhibitor CIP (20 U/ml) was also added to some of these groups. The cell lysates
were immunoprecipitated with anti-Flag antibody and immunoblotted with anti-PIAS1 antibody. Western blot against Flag, PIAS1 and
SUMO-1 for cell lysates only was used as loading controls. The sumoylated Hes-1 bands are shown in the bracket. Each experiment was performed twice.
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for the SUMO reaction (Figure 2F, upper panel), and muta-
tion of this Trp residue to Ala was shown to lose PIAS1 E3
ligase activity [21]. Various combinations of Flag-Hes-1,
Myc-SUMO-1, EGFP-PIAS1WT or EGFP-PIAS1W372Aplasmids were transfected to HEK293T cells for immuno-
blot. Results revealed that PIAS1WT transfection ap-
parently promotes the SUMOylation of Hes-1, but
PIAS1W372A transfection completely blocked this ef-
fect (Figure 2F, lower panel).
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Next, we examined whether Hes-1 SUMOylation is altered
in response to external stimuli and here, H2O2 was used as
a stimulus. The reason to use H2O2 is because that H2O2
causes oxidative stress in many cell lines studied and that
H2O2 induces global protein SUMOylation [22]. Flag-Hes-
1WT plasmid was transfected to HEK293T cells with the
addition of different concentrations of H2O2. The cell lys-
ate was immunoprecipitated with anti-Flag antibody and
immunoblotted with anti-Hes-1 and anti-SUMO-1 anti-
bodies. Results revealed that H2O2 (ranging from 0.01 mM
to 0.5 mM) produced an apparent and dose-dependent in-
crease in Hes-1 SUMOylation (Figure 3A). Further time-
course study revealed that H2O2 (0.2 mM) produced a
time-dependent increase in Hes-1 SUMOylation up to 4 h
after H2O2 treatment (Figure 3B). We then examined
whether SUMO-modification of endogenous Hes-1 could
be observed under H2O2 treatment. HEK293T cells were
transfected with Myc-SUMO-1 plasmid with or without
H2O2 co-treatment. The cell lysates were immunoprecipi-
tated with anti-Myc antibody and immunoblotted with
anti-Hes-1 and anti-SUMO-1 antibody. Results revealed
that endogenous Hes-1 SUMOylation was consistently ob-
served upon Myc-SUMO-1 transfection, but H2O2 further
enhanced the SUMOylation of Hes-1 (Figure 3C). We next
examined whether H2O2 increases the association between
PIAS1 and Hes-1, which would result in enhanced Hes-1
SUMOylation, and whether this is PIAS1 phosphorylation-
dependent. H2O2 was added to HEK293T cells for different
time periods and results indicated that H2O2 treatment in-
creased the phosphorylation level of PIAS1 at Ser90, and
this effect was most apparent 0.5 h later; but H2O2 did not
alter the expression level of PIAS1 (Figure 3D, upper
panel). Next, Flag-Hes-1WT plasmid was co-transfected
with EGFP-PIAS1WT plasmid or the phosphorylation mu-
tant plasmid EGFP-PIAS1S90A to HEK293T cells together
with the addition of H2O2, and the interaction between
PIAS1 and Hes-1 was examined 4 h after H2O2 treatment.
Results revealed that H2O2 apparently increased the associ-
ation between PIAS1 and Hes-1 (lane 2 vs. lane 5), but this
effect was diminished when EGFP-PIAS1S90A, instead of
EGFP-PIAS1WT, was transfected (lane 5 vs. lane 6)
(Figure 3D, lower panel). The role of PIAS1 phosphoryl-
ation was further confirmed by the result that treatment
of CIP, a phosphatase, reduced the association between
PIAS1 and Hes-1 that was induced by H2O2 treatment
(lane 4 vs. lane 6) (Figure 3E). In addition, immunoblot
against Flag (longer exposure) showed the absence of the
slowly migrating bands just above 43 kDa in the presence
of CIP.
Identification of the major SUMO acceptors on Hes-1
There are 15 lysine residues on the Hes-1 protein; how-
ever, no consensus SUMO-substrate motif (ψ-K-X-E,where ψ stands for a hydrophobic amino acid) was
found on Hes-1, therefore, we have constructed individ-
ual lysine residue mutant for identification of the target
SUMOylation site(s) on Hes-1 in the cell. Results re-
vealed that PIAS1 consistently sumoylated Hes-1, but
the intensity of Hes-1 SUMOylation was significantly
decreased when Flag-Hes-1K8R, Flag-Hes-1K27R or
Flag-Hes-1K39R was transfected (p < 0.001, p < 0.001
and p < 0.01, respectively) (Figure 4A and B). On the
other hand, transfection of Flag-Hes-1K86R and Flag-Hes-
1K109R both increased the intensity of Hes-1 SUMOyla-
tion (p < 0.05 and p < 0.01, respectively) (Figure 4A and B).
Because Hes-1 could be ubiquinated at both K86 and K109
[23], mutation of Hes-1 at these two residues would de-
crease the ubiquitylation of Hes-1 that may result in the
stabilization of Hes-1 and consequently, the elevation of
Hes-1 SUMOylation. Based on the above results, we then
generated the Hes-1 triple sumo-mutant construct targeted
to K8, K27 and K39 residues (Hes-1 3KR) and further ex-
amined the effects of Hes-1K8R, Hes-1K27R, Hes-1K39R
and Hes-1 3KR on Hes-1 SUMOylation. Results revealed
that transfection of each Hes-1 sumo-mutant significantly
decreased the level of Hes-1 SUMOylation (all p < 0.01),
but this effect was almost completely abolished when Flag-
Hes-1 3KR was transfected (p < 0.001) (Figure 5A and B).
Alignment of the amino acid sequence of Hes-1 indicated
that Lys8, Lys27 and Lys39 of Hes-1 are highly conserved
in different species of the vertebrate (Figure 5C).
Hes-1 SUMOylation stabilizes the Hes-1 protein
In this series of experiments we examined whether Hes-
1 SUMOylation affects the stability of Hes-1. Flag-Hes-
1WT plasmid was co-transfected with EGFP-PIAS1WT
plasmid and Myc-SUMO-1WT plasmid or Myc-SUMO-
1ΔGG plasmid to HEK293T cells and the cells were
treated with cycloheximide (50 μg/ml) for different time
periods. Cell lysates were subject to SDS-PAGE followed
by immunoblot with anti-Flag antibody (Figure 5D,
upper-left panel). Results revealed that sumoylated Hes-1
degraded slower with a half-life of 4 h approximately,
whereas the un-sumoylated Hes-1 showed a half-life for
about 2 h (Figure 5D, upper-right panel). Next, we have
transfected Flag-Hes-1 3KR or Flag-SUMO-1-fusioned
Hes-1 3KR plasmid to HEK293T cells and the cells were
treated with cycloheximide (50 μg/ml) for different time
periods. Cell lysates were similarly subject to SDS-PAGE
and immunoblotted with anti-Flag antibody (Figure 5D,
lower left panel). Results revealed that SUMO-1-fusioned
Hes-1 3KR protein showed a slower degradation rate with
a half-life for about 5 h, whereas the Hes-1 3KR protein
showed a half-life for about 2.8 h (Figure 5D, lower-right
panel). Because lysine residues are subject to both
SUMOylation and ubiquitination modifications, we
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Figure 3 PIAS1 is associated with Hes-1 and PIAS1 enhances the SUMOylation of Hes-1 in HEK293T cell. (A) Transfection of various
plasmids to HEK293T cells followed by western blots against EGFP and various tags. (B) EGFP-Hes-1, Myc-SUMO-1 and different doses of Flag-Pc2
plasmids were transfected to HEK293T cells and western blots against EGFP and different tags are shown. (C) siRNA against PIAS1, PIAS2 and
PIAS3 was transfected to HEK293T cells and western blots against Flag and PIAS proteins (PIAS1, PIAS2 and PIAS3) are shown. (D) Flag-Hes-1WT
and EGFP-PIAS1WT plasmids were co-transfected to HEK293T cells and confocol image showing the sub-cellular localization of Hes-1 (red) and
PIAS1 (green). The nuclei were visualized with DAPI staining (blue). Scale bar equals 10 μm. (E) Flag-Hes-1WT and EGFP-PIAS1WT plasmids were transfected
to HEK293T cells followed by immunoprecipitation and western blot showing Hes-1 association with PIAS1 (left panel) and vice versa (right panel). (F) Various
combinations of Flag-Hes-1, Myc-SUMO-1, EGFP-PIAS1WT or EGFP-PIAS1W372A plasmid were co-transfected to HEK293T cells and the cell lysate was subject
to western blot against various tags. The sumoylated Hes-1 bands are shown in the bracket. Each experiment was performed twice.
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Hes-1WT or Flag-Hes-1 3KR plasmid was co-transfected
with His-ubiquitin plasmid to HEK293T cells and the cell
lysates were immunoprecipitated with anti-Flag antibody
followed by immunoblotting with anti-Flag and anti-
His antibody. Results revealed that the Hes-1WT and
Hes-1 3KR proteins showed a similar ubiquitination
level (Figure 5E, right panel). In addition, we have also
examined whether Hes-1 3KR is correctly localized in
the cell. EGFP-tagged Hes-1WT and Hes-1 3KR plas-
mids were transfected to HEK293T cells and the cells
were stained with DAPI (blue). Results revealed that
Hes-1 3KR showed the same localization as Hes-1 WT
does and the merged images indicated that they both
are localized in the nucleus (Figure 5F).
PIAS1 SUMOylation of Hes-1 at these three lysine resi-
dues was further examined here. Flag-Hes-1WT or Flag-
Hes-1 3KR plasmid was co-transfected with EGFP-PIAS1
and Myc-SUMO-1 to HEK293T cells. Cells were lysed
with RIPA buffer containing 20 mM NEM and subject to
immunoprecipitation followed by immunoblotting. Re-
sults revealed that transfection of either Flag-Hes-1WT or
Flag-Hes-1 3KR yielded approximately equal amount of
the Hes-1 protein when anti-Hes-1 antibody was used
(Figure 5G, left panel), but the association between
Hes-1 and PIAS1 was reduced when Flag-Hes-1 3KR
was transfected (Figure 5G, lower panel). Furthermore,
co-transfection of EGFP-PIAS1, Myc-SUMO-1 with Flag-
Hes-1WT showed apparent bands for sumoylated Hes-1
when immunoblotted with anti-Hes-1 antibody and anti-
SUMO-1 antibody, but Hes-1 SUMOylation was abolished
when Flag-Hes-1 3KR was transfected (Figure 5G, middle
and right panels). Hes-1 SUMOylation was further en-
hanced upon H2O2 treatment (lane 2 vs. lane 5, Figure 5G,
right panel), but this effect was completely abolished
when Flag-Hes-1 3KR was transfected (lane 5 vs. lane 6,
Figure 5G, right panel).
Hes-1 SUMOylation is Hes-1 phosphorylation-independent
and vice versa
Interplay between protein SUMOylation and protein phos-
phorylation has been suggested [24,25]. Here, we examined
whether Hes-1 SUMOylation is Hes-1 phosphorylation-
dependent. The Hes-1WT and Hes-1 phosphorylationmutant plasmids at Ser37, Ser38 and Ser263 were
transfected to HEK293T cells with the co-transfection
of EGFP-PIAS1 and Myc-SUMO-1. The cell lysates
were subject to immunoprecipitation and immunoblot-
ting. Results revealed that PIAS1 consistently sumoy-
lated Hes-1, but Hes-1 SUMOylation was not affected
when Hes-1S263A and Hes-1S37AS38A were transfected
(Figure 5H). We further examined whether SUMOylation
of Hes-1 affects the phosphorylation of Hes-1. Flag-Hes-
1WT and different Flag-Hes-1 sumo-mutant plasmids
were transfected to HEK293T cells and the cell lysates
were subject to western blot. Results revealed that trans-
fection of any Hes-1 sumo-mutant did not affect the
phosphorylation level of Hes-1 at Ser263. Transfection of
Hes-1S263A was used as a negative control (Figure 5I).
Hes-1 binds to the GADD45α promoter and blockade of
Hes-1 SUMOylation reduces Hes-1 binding to GADD45α
and decreases Hes-1 suppression of GADD45α expression
SUMOylation of transcription factors has been shown to
affect their DNA-binding activity [26]. Hes-1 SUMOyla-
tion has not been reported previously, but Hes-1 was
found to mediate cell survival upon amyloid-beta insult
[27]. However, the underlying mechanism of the protect-
ive effect of Hes-1 is not fully understood. Here we
aimed to examine whether Hes-1 SUMOylation may
affect cell survival through alteration of Hes-1 binding
to DNA promoter and downstream gene expression. A
variety of genes are known to be responsive to Hes-1
[28]. There are also many known stress sensors in the
cell. In considering both factors we have carried out a
preliminary study examining the effects of knockdown
of Hes-1 on the expression of E2F1 and Growth Arrest
and DNA Damage-inducible 45α (GADD45α). It turned
out that Hes-1 had a more apparent effect in suppress-
ing GADD45α expression. In addition, PIAS1 was found
to negatively regulate the expression of GADD45α [29].
Based on these results, we have therefore chosen GADD45α,
an important stress sensor in the cell [30], for the present
study. GADD45α transcript can be rapidly induced by many
types of DNA-damaging agents including UV-irradiation
[31], alkylation agent [32], and oxidizing agents such as
H2O2 [33-35]. Accumulative evidence indicates that
GADD45α is involved in a wide range of biological
AB
Figure 4 Identification of candidate SUMO sites on Hes-1. Flag-Hes-1WT plasmid or individual Flag-Hes-1 lysine residue mutant plasmid was
co-transfected with Myc-SUMO-1 and EGFP-PIAS1 to HK293T cells and the cell lysate was subject to western blot against various tags. (A) Gel
pattern showing Hes-1 SUMOylation upon transfection of Hes-1 lysine residue mutant from Lys8 (K8R) to Lys86 (K86R). The quantification result is
shown in the lower panel. (B) Gel pattern showing Hes-1 SUMOylation upon transfection of Hes-1 lysine residue mutant from Lys109 (K109R) to
Lys215 (K215R). Lysine residue mutants from Lys8 to Lys58 were repeated for the purpose of comparison. The quantification result is shown in the
lower panel. Results were obtained from two independent experiments. The sumoylated Hes-1 bands are shown in the bracket. Data are expressed as
mean ± SEM (standard error of mean). * p < 0.05, ** p < 0.01 and # p < 0.001.
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Figure 5 Hes-1 SUMOylation stabilizes Hes-1, and Hes-1 SUMOylation and Hes-1 phosphorylation are independent each other. (A)
EGFP-PIAS1WT and Myc-SUMO-1 were co-transfected with Flag-Hes-1WT or Flag-Hes-1 sumo-mutant for immunoblot analysis against various tags.
The quantitative result was shown in (B). (C) Sequence alignment showing amino acid sequences around the three SUMOylation sites on Hes-1
in different species of animals by using the ClustalW web-based tool. (D) Flag-Hes-1WT and EGFP-PIAS1WT were co-transfected with Myc-SUMO-1
or Myc-SUMO-1ΔGG to cells and cycloheximide was added to the cell for different time periods (upper panel). In addition, Flag-Hes-1 3KR or
Flag-SUMO-1-Hes-1 3KR was transfected to HEK293T cells and cycloheximide was added to the cell for different time periods (lower panel).
The cell lysate was subject to immunoblot using antibody as indicated. A representative gel pattern and the quantitative result are shown.
(E) Flag-Hes-1WT or Flag-Hes-1 3KR was co-transfected with His-ubiquitin to HEK293T cells. The cell lysate was immunoprecipitated with
anti-Flag antibody and immunoblotted with antibodies against Flag or His. (F) Confocol images show the localization of EGFP-Hes-1WT and
EGFP-Hes-1 3KR and co-localization with DAPI. Scale bar equals 10 μm. (G) EGFP-PIAS1WT and Myc-SUMO-1 were co-transfected with Flag-Hes1WT
or Flag-Hes-1 3KR to HEK293T cells with or without H2O2 treatment. The cell lysate was immunoprecipitated with anti-Flag antibody followed by
immunoblot against Hes-1 (left and middle panels), SUMO-1 (right panel), and PIAS1 (left-lower panel). (H) EGFP-PIAS1WT and Myc-SUMO-1
were transfected with wild-type or phosphorylation site mutant plasmids into HEK293T cell, and the cell lysate was subject to immunoblot against
various tags. (I) Flag-Hes-1WT, Flag-Hes-1-S263A or different Flag-Hes-1 sumo-mutant was transfected to HEK293T cells for immunoblot
against Flag or pSer263-Hes-1. The quantified results are shown (lower panel). The sumoylated or Ubiquitinated Hes-1 bands are shown in
the bracket. Each experiment was performed twice. CHX: cycloheximide, Ub: ubiquitin.
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differentiation, senescence, and apoptosis [36]. Bioinfor-
matic analysis indicated that there are three N-boxes
(CACNAG), which is specific for Hes-1 binding, within
1 kb from the transcription start sites of human GADD45α
promoters (nt -885 ~ nt -880, nt -849 ~ nt -844 and nt
-763 ~ nt -758) (Figure 6A). To study whether Hes-1 actu-
ally binds to the GADD45α promoter, ChIP assay was
performed. Results showed that Hes-1 apparently binds
to the GADD45α promoter (Figure 6B). The PCR product
(156 bp) from ChIP assay was also observed by ChIP-PCR
and DNA electrophoresis (Figure 6B, left panel).
Among the three SUMOylation residues identified on
Hes-1, Lys39 is located in the basic domain of Hes-1,
which confers Hes-1 DNA-binding activity during tran-
scriptional repression [37]. This suggests that SUMOyla-
tion of Hes-1 may be associated with the DNA binding
activity of Hes-1. To test this hypothesis, the DNA-
binding activity of Hes-1WT and Hes-1 3KR was ex-
amined by ChIP-PCR. Results revealed that Hes-1WT
consistently binds to the GADD45α promoter, but Hes-1
3KR apparently decreased the binding activity to the
GADD45α promoter (Figure 6C, left panel). We next ex-
amined the effect of mutation of Lys39 alone on Hes-1
DNA- binding. Result revealed that mutation of Lys39
alone decreased Hes-1 binding to GADD45α promoter
for approximately 55%, but it is not sufficient to block
Hes-1 DNA-binding (Figure 6C, middle panel). This latter
result suggests that Lys8 and Lys27, the target sumo sites
on Hes-1, also play an important role in Hes-1 DNA bind-
ing. To further address this issue, we have examined the
DNA binding activity of Hes-1WT and SUMO-1-fusioned
Hes-1. Result from ChIP-PCR revealed that SUMO-1-
fusioned Hes-1 showed approximately three-fold increase
in DNA binding to GADD45α promoter than Hes-1WT
did (Figure 6C, right panel). Next, we examined whether
blockade of Hes-1 SUMOylation affects the promoter ac-
tivity of GADD45α. Human GADD45α promoter (nt -920to nt +289) was cloned from the genomic library of
HEK293T cells and co-transfected with different doses
of the Flag-Hes-1WT or Flag-Hes-1 3KR plasmid to
HEK293T cells for luciferase reporter assay. Results
indicated that Flag-Hes-1WT dose-dependently sup-
pressed GADD45α promoter activity (p < 0.05, p < 0.01
and p < 0.001), but this effect was diminished by Flag-
Hes-1 3KR also in a dose-dependent manner (p < 0.05
or p < 0.01) (Figure 6D). Furthermore, results from quanti-
tative PCR indicated that transfection of Flag-Hes-1WT
plasmid decreased GADD45α mRNA level dose-de-
pendently (p < 0.05, p < 0.01 and p < 0.001), but this effect was
partially reversed by Flag-Hes-1 3KR transfection (p < 0.01
for 600 ng dose) (Figure 6E). The same results were found
with GADD45α protein expression (p < 0.001 and p < 0.01)
(Figure 6F). Plasmid transfection and expression was con-
firmed by western blot against Flag (Figure 6F). Because
GADD45α is a stress sensor, next we examined the effect
of Hes-1 SUMOylation on GADD45α protein expression
under the challenge of H2O2. Results revealed that H2O2
dramatically increased the expression of GADD45α
(p < 0.001). This effect was decreased by Flag-Hes-1WT
transfection (p < 0.01), but Flag-Hes-1 3KR was less able
to produce the same effect (p < 0.05 compared with the
Flag-Hes-1WT group) (Figure 6G). Plasmid transfection
and expression was confirmed by western blot against Flag
(Figure 6G).
Because Hes-1 suppressed GADD45α promoter activity
and expression, we expect that knockdown of Hes-1 expres-
sion should increase GADD45α promoter activity and ex-
pression. This issue was examined here. Two different sets
of Hes-1 siRNA were transfected to HEK293T cells, respect-
ively. Results revealed that both Hes-1 siRNA transfec-
tions increased GADD45α promoter activity (both p < 0.01)
(Figure 6H) and endogenous GADD45α mRNA level (both
p < 0.05) (Figure 6I). We further examined whether knock-
down of Hes-1 also increases GADD45α protein expres-
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Figure 6 Hes-1 binds to the GADD45α promoter and blockade of Hes-1 SUMOylation reduces Hes-1 binding to GADD45α and decreases
Hes-1 suppression of GADD45αexpression. (A) pGL3-GADD45α-P: cloned GADD45α promoter. N-boxes and primers used for Hes-1 ChIP assay
were shown. (B) ChIP PCR was performed using Hes-1 antibody (or mouse IgG) and the primer for GADD45α promoter. The PCR product (left
panel) and the result of ChIP real-time PCR (right panel) were shown. (C) Flag-Hes-1WT, Flag-Hes-1 3KR or Flag-SUMO-1-fusioned Hes-1WT was
transfected to cells for ChIP PCR with anti-Flag antibody and primers for GADD45α promoter. Input: PCR product from input lysate. (D) Different
doses of Flag-Hes-1WT or Flag-Hes-1 3KR was co-transfected with pGL3-GADD45α-P to cells for promoter activity assay. Different doses of
Flag-Hes-1WT or Flag-Hes-1 3KR was transfected to cells and GADD45α mRNA (E) and protein (F) expression were analyzed by real-time
PCR and immunoblot respectively, and the quantified results were shown. (G) Flag-Hes-1WT or Flag-Hes-1 3KR was transfected to cells with
or without H2O2 treatment followed by immunoblot against GADD45α and Flag. The quantified result is shown below. (H) Two sets of Hes-1
siRNA and 0.4 μg of pGL3-GADD45α-P were co-transfected to cells for promoter activity assay. Two sets of Hes-1 siRNA were transfected to cells with
or without the addition of H2O2 for GADD45α mRNA (I) and protein (J) expression analysis by real-time PCR and immunoblot against GADD45α and
Flag respectively. Data for luciferase activity and western blot are expressed as that in Figure 4. Values for mRNA measure are averaged from two
independent experiments with mean value for the control group normalized to 1.0. Other values are normalized to the control value. Each
experiment was performed twice. * p < 0.05, ** p < 0.01 and # p < 0.001.
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dition of different concentrations of H2O2. Results revealed
that H2O2 produced a dose-dependent increase in GADD45α
protein expression (p < 0.05, p < 0.01 or p < 0.001), and both
Hes-1 siRNA transfections increased GADD45α protein
expression under each dose of H2O2 examined (p < 0.05
or p < 0.01) (Figure 6J). A representative gel pattern from
western blot is shown (Figure 6J, left panel).
PIAS1 enhances the suppressing effect of Hes-1 on
GADD45α expression that is blocked by Hes-1 3KR
The above results showed that blockade of Hes-1 SUMOy-
lation decreased the transcriptional suppression activity of
Hes-1 on GADD45α expression. Here we further exam-
ined the role of Hes-1 SUMOylation in regulation of
GADD45α promoter activity and expression by overex-
pression of SUMO-1, PIAS1WT or PIAS1W372A, Hes-
1WT or Hes-1 3KR to HEK293T cells. Results revealed
that transfection of Flag-Hes-1WT plasmid consist-
ently suppressed GADD45α promoter activity (p < 0.05)
(Figure 7A, lane 3 vs. lane 2), and co-transfection of Flag-
PIAS1 further enhanced the suppressing effect of Hes-1
(p < 0.05 and p < 0.01 for 6 ng and 60 ng of Flag-PIAS1)
(Figure 7A, lane 4, 5 vs. lane 3), but co-transfection of
Flag-PIAS1W372A antagonized the effect of Hes-1 on
GADD45α promoter activity (p < 0.01) (Figure 7A, lane
6 vs. lane 3). Further, the enhancing effect of Flag-
PIAS1 was blocked by co-transfection of Flag-Hes-1
3KR (p < 0.05 or p < 0.001) (Figure 7A, lane 7-9 vs. lane
3-5). The same plasmid transfection yielded similar re-
sults on GADD45α mRNA expression (p < 0.05, p < 0.01
or p < 0.001) (Figure 7B) and protein expression (p < 0.05,
p < 0.01 or p < 0.001) (Figure 7C). Plasmid transfection
and expression was confirmed by western blot against Flag
(Figure 7C).
Results from Figure 6D and E showed that Hes-1
negatively regulates GADD45α promoter activity and
mRNA expression, here we further examined the role of
PIAS1 in regulation of GADD45α expression. Two setsof PIAS1 siRNA were transfected to HEK293T cells to
study this issue. Results revealed that both sets of PIAS1
siRNA transfection increased GADD45α promoter ac-
tivity (both p < 0.001) (Figure 7D). Both PIAS1 siRNA
transfetions also decreased PIAS1 expression (Figure 7D,
lower panel). Similarly, both sets of PIAS1 siRNA trans-
fection increased GADD45α mRNA level (both p < 0.05)
(Figure 7E) and GADD45α protein level (Figure 7F). The
effectiveness of both PIAS1 siRNA transfections was con-
firmed by a decreased level of PIAS1 expression from
western blot (Figure 7F).
Effects of GADD45α on H2O2-induced cell apoptosis
It is shown that GADD45α is involved in cell apoptosis
[38,39] or anti-apoptosis [40], and this effect is dependent
upon the stimulus and cell type studied. Here we exam-
ined whether GADD45α produces toxicity to HEK293T
cells and whether GADD45α potentiates the effect of
H2O2 on cell apoptosis. Results from TUNEL (terminal
deoxynucleotidyl transfease dUTP nick-end labeling) assay
revealed that transfection of Flag-GADD45α caused cell
apoptosis in a dose-dependent manner (p < 0.01 for
0.6 μg), and it further potentiated H2O2-induced apoptosis
(p < 0.001 or p < 0.01) (Figure 7G). Furthermore, the tox-
icity of H2O2 was attenuated by transfection of GADD45α
siRNA in a dose-dependent manner (p < 0.01 or p < 0.001)
(Figure 7H). Plasmid and siRNA transfection and protein
expression were confirmed by western blot using anti-Flag
antibody (Figure 7G, lower panel) and anti-GADD45α
antibody (Figure 7H, lower panel).
Hes-1 and PIAS1 protect against H2O2-induced apoptosis
through Hes-1 SUMOylation
The above results showed that Hes-1 suppressed GADD45α
promoter activity and GADD45α expression and these ef-
fects were alleviated by transfection of the Hes-1 sumo-
mutant Hes-1 3KR. In addition, GADD45α yielded cell
apoptosis in HEK293T cells. In this experiment, we exam-
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Figure 7 PIAS1 enhances the suppressing effect of Hes-1 on GADD45α expression that is blocked by Hes-1 3KR. Different doses of
Flag-PIAS1WT or Flag-PIAS1W372A plasmid was co-transfected with Myc-SUMO-1 and various doses of Flag-Hes-1WT or Flag-Hes-1 3KR plasmid
together with 0.4 μg of GADD45α promoter construct to HEK293T cells for determination of (A) GADD45α promoter activity and (B) GADD45α
mRNA level by real-time PCR. (C) Different doses of Flag-PIAS1WT or Flag-PIAS1W372A plasmid was co-transfected with various doses of Flag-Hes-1WT
or Flag-Hes-1 3KR plasmid to HEK293T cells and western blot against GADD45α and Flag was performed. The quantified result is shown on the right panel.
(D) Two sets of PIAS1 siRNA and 0.4 μg of GADD45α promoter construct were transfected to HEK293T cells and GADD45α promoter activity was determined
48 h later. Two sets of PIAS1 siRNA were transfected to HEK293T cells and (E) GADD45αmRNA level and (F) GADD45α protein level were determined 48 h
later. The effectiveness of PIAS1 siRNA transfection is confirmed by western blot against PIAS1. (G) Two doses of Flag-GADD45α plasmid was transfected to
cells with the addition of different concentrations of H2O2 and cell apoptosis was determined by TUNEL assay. Western blot against the Flag-tag confirms
plasmid transfection and expression. (H) Two concentrations of GADD45α siRNA was transfected to HEK293T cells with the addition of different
concentrations of H2O2 and cell apoptosis was determined by TUNEL assay. Western blot against GADD45α confirms the effectiveness of
GADD45α siRNA transfection. Data are expressed as that in Figure 6. Each experiment was performed twice. * p < 0.05, ** p < 0.01 and # p < 0.001.
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Hes-1 3KR. Because previous results revealed that H2O2
ranging from 0.01 mM to 0.5 mM produced consistent and
dose-dependent increase in Hes-1 SUMOylation (Figure 2A),
we have adopted concentrations of H2O2 ranging from
0.05 mM to 0.2 mM for the present experiment. Various
Flag-tagged Hes-1 plasmids and GADD45α plasmid were
transfected to HEK293T cells and their effects on cell sur-
vival were determined by CCK-8 assay upon H2O2 chal-
lenge. Results revealed that H2O2 consistently decreased cell
survival in a dose-dependent manner (p < 0.001). Over-
expression of Hes-1 protected against this effect of
H2O2 (for 0.05 mM and 0.1 mM of H2O2) (p < 0.05 or
p < 0.01). But the protective effect of Hes-1 was dimin-
ished by co-transfection of GADD45α (for 0.05 mM
and 0.1 mM of H2O2) (p < 0.05 or p < 0.01). Further-
more, the protective effect of Hes-1 was no longer ob-
served when Flag-Hes-1 3KR, instead of Flag-Hes-
1WT, was transfected (for 0.05 mM and 0.1 mM of
H2O2) (p < 0.01) (Figure 8A). When the concentration
of H2O2 is too high (0.2 mM), neither the protective effect
of Hes-1 nor the pro-apoptotic effect of GADD45α
and Hes-1 3KR was observed (p > 0.05). Plasmid trans-
fection and expression was confirmed by western blot
against Flag and a representative gel pattern for con-
trol and 0.1 mM H2O2 is shown (Figure 8A, lower
panel). On the other hand, knockdown of Hes-1 ex-
pression by Hes-1 siRNA transfection at a concentra-
tion that did not produce a significant effect alone,
potentiated H2O2-induced decrease in cell survival (p <
0.05) (Figure 8B). But knockdown of GADD45α expression
suppressed the decreased cell survival seen with Hes-1
siRNA transfection (p < 0.05) (Figure 8B). The effectiveness
of Hes-1 siRNA and GADD45α siRNA transfection was
confirmed by decreased Hes-1 and GADD45α expression,
respectively, from western blot (Figure 8B, lower panel).
PIAS1 protects against H2O2-induced apoptosis through
SUMOylation of Hes-1
The above results showed that Hes-1 protects against
H2O2-induced apoptosis and this effect was preventedby Hes-1 3KR. Here we examined whether enhanced
SUMOylation of Hes-1 facilitates the protective effect of
Hes-1. The Flag-PIAS1 plasmid was transfected alone or
co-transfected with Flag-Hes-1WT or Flag-Hes-1 3KR
plasmid to HEK293T cells and their effects on cell sur-
vival were determined by CCK-8 assay upon H2O2 in-
sult. Results revealed that H2O2 consistently decreased
cell survival in a dose-dependent manner (p < 0.001).
Overexpression of PIAS1 protected against this effect of
H2O2 (p < 0.05). The protective effect of PIAS1 was fur-
ther enhanced by Flag-Hes-1WT co-transfection (p <
0.05), but this enhancing effect of Hes-1 was blocked by
Flag-Hes-1 3KR co-transfection (p < 0.01) (Figure 8C).
Similarly, the protective effect of PIAS1 and Hes-1 and
the blockade effect of Hes-1 3KR were not observed
when the concentration of H2O2 is too high (0.2 mM)
(p > 0.05). Plasmid transfection and expression was con-
firmed by western blot against Flag and a representative
gel pattern for control and 0.1 mM H2O2 is shown
(Figure 8C, lower panel). Furthermore, we examined
the effect of PIAS1 overexpression on cell survival.
Different amount of Flag-PIAS1 plasmid was trans-
fected to HEK293T cells and cell survival was deter-
mined by CCK-8 assay 48 h later. Results revealed that
transfection of Flag-PIAS1 from 0.2 μg to 0.8 μg did
not produce an effect on cell survival (p > 0.05). How-
ever, transfection of Flag-PIAS1 at 1.6 μg apparently
decreased cell survival (p < 0.01) (Figure 8D). PIAS1
plasmid transfection and expression was confirmed by
immunoblot against Flag and PIAS1 (Figure 8D, lower
panel).
Discussion
In this study, we have identified the transcriptional re-
pressor Hes-1 as a novel SUMO substrate. In the cell,
endogenous Hes-1 SUMOylation was not readily ob-
served due to low Hes-1 antibody efficiency and very
few amount of IP product obtained. Thus, overexpres-
sion of Myc-SUMO-1 (but not overexpression of Hes-
1) was adopted which allows the detection of Hes-1
SUMOylation (Figure 1D), suggesting that endogenous
DC
A B
Figure 8 Hes-1 and PIAS1 both protect against H2O2-induced apoptosis through SUMOyaltion of Hes-1, and high dose of PIAS1 decreases
cell survival. (A) Flag-Hes-1WT or Flag-Hes-1 3KR plasmid, alone or in combination with Flag-GADD45α, was transfected to HEK293T cells together
with different concentrations of H2O2 for examination of cell survival by using CCK-8 activity assay. Western blot against the Flag-tag confirms the
transfection and expression of Hes-1 plasmid and GADD45α plasmid, and a representative gel pattern under 0.1 mM H2O2 treatment is shown (lower
panel). (B) Hes-1 siRNA (20 nM), alone or together with GADD45α siRNA, was transfected to HEK293T cells with or without the addition of H2O2
(0.05 mM) and cell survival was determined by CCK-8 activity assay. The effectiveness of Hes-1 siRNA and GADD45α siRNA transfections was confirmed
by western blot against Hes-1 and GADD45α. (C) Flag-PIAS1WT plasmid, alone or in combination with Flag-Hes-1WT or Flag-Hes-1 3KR plasmid was
transfected to HEK293T cells together with different concentrations of H2O2 for examination of cell survival by using CCK-8 activity assay. Western blot
against the Flag-tag confirms the transfection and expression of PIAS1 plasmid and Hes-1 plasmid, and a representative gel pattern under 0.1 mM
H2O2 treatment is shown (lower panel). (D) Different doses of Flag-PIAS1WT plasmid were transfected to HEK293T cells and cell viability was
determined by CCK-8 activity assay. Flag-PIAS1WT transfection and expression was confirmed by western blot against PIAS1 and Flag. Data
are expressed as mean ± SEM from two independent experiments. * p < 0.05 and ** p < 0.01.
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ever, it is known that the SUMO molecule is attached
to most substrates at the lysine residue (K) of the ψ-K-
X-E consensus motif, which is directly bound by the
E2 ligase UBC9. This direct interaction explains why
E1 and E2 only are sufficient to sumoylate many sub-
strates at the correct lysine residue in the absence of
any E3 [6]. Actually, SUMO attach at non-consensus
sites has also been reported and it is suggested that the
E3 ligase activity is particularly important for SUMOy-
lation at atypical consensus motif [6,41]. Therefore, the
association of E3 ligase and Hes-1 was further exam-
ined in our study. In support of this hypothesis, we
have found that PIAS1 greatly enhanced the SUMOyla-
tion of Hes-1, and this effect was abolished by both
PIAS1 siRNA and PIAS1W372A transfections. Further-
more, PIAS2 and PIAS3 also apparently increased the
SUMOylation of Hes-1, but RanBP2 and Pc2 did not
affect the SUMOylaiton of Hes-1. These results together
reveal the important role of the PIAS family E3 ligase in
Hes-1 SUMOylation in the cell.
There are seven members of the Hes protein in the
Hes protein family (Hes-1 to Hes-7) [28]. Among these
Hes proteins, Hes-1 and Hes-5 are important Notch ef-
fectors. Once activated by Delta, the NICD is cleaved by
γ-secretase and leads to the induction of Hes-1 and Hes-
5 expression [42,43]. In the absence of Hes-1 and Hes-5,
NICD is unable to inhibit neurogenesis [1]. Studies using
knockout mice have shown that Hes-1 and Hes-5 oper-
ate in a common signaling pathway and they functionally
compensate each other [44,45]. However, in the present
study we have found that Hes-1 could be SUMO modi-
fied by PIAS1, but Hes-5 could not. In another study, we
have found that Hes-1 strongly regulates GluR1 expres-
sion in cultured cortical neurons but Hes-5 only moder-
ately does so [3]. These results together suggest that
although both Hes-1 and Hes-5 are Notch effectors,
their post-translational modifications could be different
and it is conceivable that they also participate in differ-
ent cellular functions.
In the present study, we have identified Lys8, Lys27
and Lys39 as the major SUMO sites on Hes-1 and muta-
tion at these residues significantly decreased the DNA
binding activity of Hes-1 to GADD45α promoter. Among
these three lysine residues, Lys39 is located in the basic
domain of GADD45α and Hes-1 can directly bind to
DNA through its basic domain. Sequence alignment indi-
cated that Lys39 of Hes-1 is highly conserved in different
species of vertebrates. Facilitation of DNA binding upon
protein SUMOylation has also been demonstrated for
other transcription factors. For example, SUMOylation of
heat shock transcription factor 2 (HSF2) at Lys82, which
is also located in the DNA binding domain, results in con-
formational change of HSF2 that facilitates trimerizationand DNA-binding [46]. SUMOylation of Oct4 at Lys118,
which is located near the DNA binding domain, also
causes conformational change of Oct4 that enhances its
DNA binding activity [47]. Moreover, SUMOylation of
signal transducer and activator of transcription-1 (STAT1)
at Lys703 was found to enhance DNA-binding of STAT1
which further facilitates spatial memory formation in rats
[11]. Furthermore, studies from NMR spectroscopy and
protein-DNA cross-linking experiments reveal that the
SUMO-1 molecule also possesses DNA-binding activity
and SUMO-1 specifically binds to dsDNA without par-
ticular sequence [48]. It is conceivable that both the basic
domain and the SUMO-1 molecule near the basic domain
contribute to the DNA-binding activity of Hes-1. Whether
the N-terminal domain of Hes-1 also confers a DNA-
binding activity requires further investigation.
In this study we have found that GADD45α is a novel
target of Hes-1. Hes-1 directly bound to the promoter of
GADD45α and suppressed its promoter activity and gene
expression. Sequence analysis indicated that, in addition
to three N-boxes, there are also six E-boxes on the
GADD45α promoter (nt. -867 ~ -862, nt. -852 ~ -849,
nt. -773 ~ -768, nt. -771 ~ -766, nt. -716 ~ -711 and
nt. -340 ~ -335). Therefore, Hes-1 may also suppress
GADD45α expression through passive repression by
preventing Mash1/E47 from binding to the E-box of
GADD45α promoter. GADD45α transcripts can be
rapidly induced by genotoxic stresses, and several tran-
scription factors are involved in this process including
p53, BRCA1, Oct1, NF-YA and WT1 [49-52]. In addition,
GADD45α expression is reduced by c-Myc under various
genotoxic stresses [53,54]. GADD45α expression could also
be induced by H2O2 treatment [35], but the underlying
mechanism is not known. In the present study, we have
found that Hes-1 suppressed the expression of GADD45α
under both normal condition and H2O2 stimulation. Fur-
thermore, GADD45α expression is implicated in cell apop-
tosis. For example, overexpression of GADD45α was found
to activate p38 MAPK and JNK and result in cell apoptosis
[39]. UV radiation-induced apoptosis in keratinocytes was
found decreased in GADD45α-deficient mice [38]. Consist-
ent with these reports, here we found that overexpression
of GADD45α enhanced, but knockdown of GADD45α de-
creased H2O2-induced apoptosis in HEK293T cells. These
results together provide a novel protective mechanism of
Hes-1 against H2O2-induced apoptosis through suppres-
sion of GADD45α expression. These results are congruent
with the reports showing that Hes-1 plays a protective role
against amyloid-beta-induced toxicity in neurons and that
Hes-1 maintains stem cell survival [27,55]. Although there
is report showing that GADD45α plays an anti-apoptotic
role [40], this is probably due to different stimuli and cell
types studied. Furthermore, we have found that Hes-1
siRNA at a concentration (20 nM) that did not affect cell
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But there are also reports showing that Hes-1 plays a pro-
apoptotic role [56,57]. One possibility to explain this dis-
crepancy is that the present study was carried out in
HEK293T cells and the expression level of Notch receptor
is very low in these cells, so the observed effects of Hes-1
on GADD45α expression and cell survival are likely unre-
lated to Notch signaling; instead, it serves as a general pro-
tective mechanism in various cell types.
On the other hand, we have also found that H2O2 from
0.01 mM to 0.5 mM produced a dose-dependent increase
in Hes-1 SUMOylation but H2O2 decreased Hes-1
SUMOylation at higher doses (1 mM and 10 mM). Re-
sults from another study have shown that H2O2 at
100 mM produces a significant increase in global SUMOy-
lation [22]. However, we did not examine Hes-1 SUMOyla-
tion by H2O2 at this concentration because most of the
cells died under this concentration of H2O2 treatment.
This is probably due to the difference between HeLa cells
and HEK293T cells in terms of their resistance to H2O2
toxicity. In addition, Hes-1 SUMOylation may be more
sensitive to the effect of H2O2 than global protein SUMOy-
lation is. Furthermore, all the sumoylated forms of Hes-1
observed in the present study under H2O2 treatment are
probably not included in global SUMOylation induced by
H2O2 from that study because all sumoylated forms of
Hes-1 are smaller than 72 kDa (Figure 1B and Figure 2A),
whereas in that study all sumoylated proteins are larger
than 100 kDa. Moreover, we have found that PIAS1 phos-
phorylation at Ser90 plays an important role in PIAS1
SUMOylation of Hes-1 in response to H2O2 stimulation.
In speculation of the possible stress-activated kinases that
phosphorylate PIAS1, IKKα and IKKβ could be the candi-
date kinases because H2O2 was shown to activate IKK ac-
tivity [58] and IKKα was shown to phosphorylate PIAS1 at
Ser90 to mediate anti-inflammation [59]. However, the
involvement of other kinases can not be ruled out. For
example, MAPK/ERK was shown to ameliorate H2O2
cytotoxicity in mouse kidney cells [60]. Whether MAPK/
ERK also phosphorylates PIAS1 in response to H2O2 chal-
lenge requires further investigation. In addition, because
Hes-1 SUMOylation down-regulated GADD45α expres-
sion, these results together suggest that H2O2-induced
SUMOylation of Hes-1 may provide an endogenous pro-
tection mechanism against H2O2 insult.
In the present study, transfection of Hes-1 3KR did not
completely block the suppressing effect of Hes-1 on
GADD45α promoter activity and protein expression
(Figure 6D and 6F). This is probably because that in
addition to Hes-1 SUMOylation that affects Hes-1
binding to the GADD45α promoter, other posttransla-
tional modifications of Hes-1 may also contribute to
these observations. For example, we have previously
found that the Hes-1 phosphorylation mutant, Hes-1S263A, decreases the stability and the transcriptional
suppressing activity of Hes-1 [3]; presumably it would
also decrease the amount of Hes-1 bound to DNA.
Therefore, endogenous Hes-1 phosphorylation may also
contribute to Hes-1 binding to the GADD45α promoter
and regulate GADD45α expression even when normal
Hes-1 SUMOylation was blocked. This speculation is sup-
ported by our findings that Hes-1 SUMOylation and Hes-
1 phosphorylation are independent each other and that
transfection of Hes-1 3KR did not completely block Hes-1
binding to the GADD45α promoter as determined by
ChIP PCR. These results also suggest that there may be a
synergistic effect of Hes-1 SUMOylation and Hes-1 phos-
phorylation on Hes-1 stabilization and Hes-1-mediated
suppression of gene transcription. But these results do not
exclude other possibilities that may also affect Hes-1 bind-
ing to the GADD45α promoter. Furthermore, the present
results revealed that Hes-1 WT and Hes-1 3KR showed a
similar ubiquitination level. These results indicated that
Hes-1 SUMOylation stabilized the Hes-1 protein. Because
protein SUMOylation was shown to affect the proteaso-
mal degradation of protein, it is possible that Hes-1
SUMOylation may cause conformational change of Hes-1
that alters the interaction between Hes-1 and its E3 ubi-
quitin ligase. But other mechanisms may also involve in it.
These results also do not exclude the possibilities that
Hes-1 3KR may cause other changes because lysine is also
subject to other post-translational modifications, such as
acetylation.
In addition, unlike Hes-1 SUMOylation which was not
previously reported in the literature, the cellular function
of Hes-1 phosphorylation has been investigated. For ex-
ample, Hes-1 was found phosphorylated by CaMKIIδ
and CaMKIIδ activation of Hes-1 switches the function
of Hes-1 from a repressor to an activator involved in
neuronal differentiation [5]. Further, phosphorylation of
Hes-1 by protein kinase C inhibits Hes-1 DNA-binding
that is essential for neurite outgrowth induced by nerve
growth factor in PC12 cells [4]. Whether Hes-1 SUMOy-
lation is also involved in these cellular functions and,
perhaps, other un-identified cellular functions requires
further investigation.
The present results also demonstrated that overexpres-
sion of PIAS1 protected against H2O2-induced cell death,
implicating that PIAS1 plays an anti-apoptotic role. These
results are inconsistent with the reports showing that
PIAS1 has a pro-apoptotic role [29,61]. One possibility to
explain this discrepancy is perhaps due to different doses
of PIAS1 used in these studies because only 0.2 μg PIAS1
plasmid DNA was transfected to HEK293T cells in the
present study, but inducible PIAS1 expression was adopted
in another study. We have similarly found that transfection
of PIAS1 plasmid at a higher dose (1.6 μg) produced cell



















Figure 9 A schematic diagram showing the relationship among PIAS1, Hes-1 SUMOylation and GADD45α expression that protects
against H2O2-induced apoptosis.
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substrate that is sumoylated by PIAS1. In this study, we
have found that co-transfection of the Hes-1WT plasmid
enhanced the anti-apoptotic effect of PIAS1 on H2O2-in-
duced cell death. This is probably because that more
Hes-1 protein is available for PIAS1 SUMOylation of
Hes-1 to take place, and Hes-1 SUMOylation plays an
anti-apoptotic role. This explanation is supported by the
observation that transfection of the Hes-1 sumo-mutant
(Hes-1 3KR) prevented the anti-apoptotic effect of
PIAS1. On the other hand, because PIAS1 inhibits STAT1
activity, the present results are congruent with the reports
showing that STAT1 regulates cell death [62,63] and
STAT1 mediates the neurotoxicity of amyloid-beta
[64], although the apoptotic role of STAT1 may dependon the cell type and the specific STAT1 dimers
formed [65,66].
Conclusion
In conclusion, we have demonstrated that Hes-1 is a novel
substrate of the SUMO E3 ligase PIAS1, and PIAS1
SUMOylation of Hes-1 stabilized Hes-1 and enhanced
the transcriptional suppressing activity of Hes-1 on
GADD45α expression. Furthermore, GADD45α increased
cell apoptosis. Thus, Hes-1 SUMOylation by PIAS1 plays
a protective role against cell apoptosis through enhanced
suppression of GADD45α expression (Figure 9). These re-
sults provide the first evidence that posttranslational
modification of Hes-1 by SUMOylation mediates cell
survival.
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